Join our daily newsletter At The Bell to receive exclusive market insights
Good morning and welcome to the second day of the week. The ASX is set to rise with futures up 29pts higher (up 0.42 per cent) as at 8:30 AEDT.
The US finished in the green overnight, a welcome change, with the S&P 500 up 1.20 per cent and the NASDAQ up 1.16 per cent.
Overnight German inflation was shown to have cooled to a more than 2-year low; the country’s economy makes up 40 per cent of the Eurozone’s and so is taken as a bellwether for the entire region.
Israel’s leader said overnight a ceasefire would not be his ideal path forward, indicating the Middle Eastern war uncertainty is set to remain for a while yet.
Fun fact: Palestine has its own stock exchange headquartered in the West Bank.
In Australia the IMARC2023 conference kicks off today over east; there’s not much in way of domestic economic data today.
Here’s what stock traders are watching pre-market:
Mantle Minerals (ASX:MTL) has released its latest quarterly.
The company commenced aircore drilling at Roberts Hill during the period and advanced key approvals.
The company finished September with $2.4 million in cash.
Shares last traded at 0.3 cents.
Mount Ridley (ASX:MRD) has released its latest quarterly.
The company highlighted its ongoing drill run for 8,000 metres targeting rare earth elements (REEs).
The company’s headline result was a 22-metre thick intersection grading at 2160ppm REEs.
Shares last traded at 0.2 cents.
Meanwhile, Hastings Technology Metal (ASX:HAS) has also released its latest quarterly.
The company reported no injuries in the period and appointed Paul Brown as CEO.
The company ended the period with $67.5 million in cash.
Shares last traded at 76.5 cents.
Arcadia Minerals (ASX:AM7) has also released its quarterly.
The company raised $1.5 million across the quarter with major shareholder Raubex Group chipping into a recent placement.
The company completed fieldwork at its Swanson lithium project over the quarter, targeting 8 known pegmatite targets.
Shares last traded at 8.5 cents.
Finally, Little Green Pharma (ASX:LGP) has – you guessed it – released its latest quarterly.
The company found itself at the end of September with $6.2 million in cash receipts.
Across the three-month window, LGP also released five new products.
Shares last traded at 16 cents.
-1200x645-380x200.jpg)
-1200x645-380x200.jpg)